Ellis Eye & Laser Medical Center El Cerrito, CA - 94530

Ellis Eye & Laser Medical Center is categorized under Clinics in El Cerrito, CA .

Ellis Eye & Laser Medical Center was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Lucia Salvador, Manager at the company’s single location by writing to 6500 Fairmount Avenue # 2, El Cerrito, California CA 94530 or by phoning (510) 525-2600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ellis Eye & Laser Medical Center
Contact Person: Lucia Salvador, Manager
Address: 6500 Fairmount Avenue # 2, El Cerrito, California 94530
Phone Number: (510) 525-2600
Website Address: elliseye.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Ellis Eye & Laser Medical Center was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Lucia Salvador, Manager for inquiries that concern Ellis Eye & Laser Medical Center by calling the company number (510) 525-2600, as your correspondence is most welcome. Additionally, the physical location of the single location of Ellis Eye & Laser Medical Center can be found at the coordinates 37.90112,-122.30074 as well as the street address 6500 Fairmount Avenue # 2 in El Cerrito, California 94530.

For its online presence, you may visit Ellis Eye & Laser Medical Center’s website at elliseye.com and engage with its social media outlets through on Twitter and on Facebook.